Mestag to develop drugs targeting fibroblasts

Country

United Kingdom

A new biotech company has been launched in the UK to develop medicines for cancer and inflammatory disease by targeting fibroblasts. Mestag Therapeutics Ltd was founded by a team of five fibroblast experts and has received seed financing of $11 million from SV Health Investors and Johnson & Johnson Innovation.